Level up your trading with our powerful tools and real-time insights all in one place.

Get Started

CLLS

Cellectis (CLLS)

Cellectis SA

Date:

Regulatory News

Text Search:

Sort by:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:CLLS

<< Previous 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 Next >>

Date	Time	Source	Headline	Symbol	Company
11/04/2021	5:02PM	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:CLLS	Cellectis SA
11/04/2021	5:00PM	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:CLLS	Cellectis SA
11/04/2021	4:49PM	GlobeNewswire Inc.	Cellectis Provides Business Update and Reports Financial Results for Third Quarter and First Nine Months 2021	NASDAQ:CLLS	Cellectis SA
11/04/2021	9:13AM	GlobeNewswire Inc.	Cellectis Announces Release of Abstracts at ASH Showcasing Updated Preliminary Clinical Data from BALLI-01 Study and First Preclinical Data from TALGlobin01	NASDAQ:CLLS	Cellectis SA
10/28/2021	4:37PM	GlobeNewswire Inc.	Cellectis to Hold Third Quarter Earnings Call on Friday, November 5, 2021 at 8AM EDT	NASDAQ:CLLS	Cellectis SA
10/19/2021	4:32PM	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:CLLS	Cellectis SA
10/19/2021	4:30PM	GlobeNewswire Inc.	Cellectis Presents Initial Preclinical Data on Two Novel Gene Therapies for Patients with RAG1 Severe Combined Immunodeficiency (SCID) and Hyper IgE syndrome at ESGCT 2021	NASDAQ:CLLS	Cellectis SA
10/12/2021	4:52PM	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:CLLS	Cellectis SA
10/12/2021	4:35PM	GlobeNewswire Inc.	Cellectis to Present Preclinical Data on UCARTMESO Supporting Anti-Tumor Activity at the Society for Immunotherapy of Cancer (SITC) 36th Annual Meeting	NASDAQ:CLLS	Cellectis SA
10/05/2021	4:32PM	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:CLLS	Cellectis SA
08/31/2021	11:13AM	Edgar (US Regulatory)	Amended Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k/a)	NASDAQ:CLLS	Cellectis SA
08/26/2021	4:43PM	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:CLLS	Cellectis SA
08/26/2021	4:34PM	GlobeNewswire Inc.	Cellectis Announces Participation in Five Investor Conferences	NASDAQ:CLLS	Cellectis SA
08/05/2021	5:08PM	Edgar (US Regulatory)	Securities Registration: Employee Benefit Plan (s-8)	NASDAQ:CLLS	Cellectis SA
08/05/2021	4:35PM	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:CLLS	Cellectis SA
08/05/2021	4:30PM	GlobeNewswire Inc.	Cellectis Provides Business Update and Reports Financial Results for Second Quarter and First Six Months 2021	NASDAQ:CLLS	Cellectis SA
07/29/2021	4:34PM	GlobeNewswire Inc.	Cellectis to Hold Second Quarter 2021 Earnings Call on Friday, August 6, 2021 at 8AM EDT	NASDAQ:CLLS	Cellectis SA
07/08/2021	7:53PM	TipRanks	2 “Strong Buy” Stocks Flirting With a Bottom	NASDAQ:CLLS	Cellectis SA
06/14/2021	4:30PM	GlobeNewswire Inc.	Cellectis’ Innovation Days event highlighted New Product Development, New Genome Surgery Platform .HEAL, and Manufacturi...	NASDAQ:CLLS	Cellectis SA
06/02/2021	5:07PM	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:CLLS	Cellectis SA
06/02/2021	2:30AM	GlobeNewswire Inc.	Cellectis S.A. Reports Results from Annual Shareholders’ General Meeting Held on June 1, 2021	NASDAQ:CLLS	Cellectis SA
05/24/2021	4:35PM	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:CLLS	Cellectis SA
05/11/2021	4:32PM	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:CLLS	Cellectis SA
05/06/2021	4:40PM	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:CLLS	Cellectis SA
05/06/2021	4:35PM	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:CLLS	Cellectis SA
05/06/2021	4:30PM	GlobeNewswire Inc.	Cellectis Provides Business Update and Reports Financial Results for First Quarter 2021	NASDAQ:CLLS	Cellectis SA
04/27/2021	6:38AM	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:CLLS	Cellectis SA
04/26/2021	4:43PM	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:CLLS	Cellectis SA
04/26/2021	4:39PM	GlobeNewswire Inc.	Cellectis’ Annual Shareholders’ General Meeting to be Held on June 1, 2021	NASDAQ:CLLS	Cellectis SA
04/09/2021	6:18AM	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:CLLS	Cellectis SA

Showing the most relevant articles for your search:NASDAQ:CLLS

<< Previous 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 Next >>

Northwest Biotherapeutics (QB)

Ethema Health (PK)

Asia Broadband (PK)

1812 Brewing (PK)

Kraig Biocraft Laborator... (QB)

Faraday Future Intellige...

Bioelectronics (PK)

Digital Brand Media and ... (PK)

Branded Legacy (PK)

Fannie Mae (QB)

Emergent Health (PK)

SMC Entertainment (PK)

Anavex Life Sciences

Delayed Upgrade Clock

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions